#WelcomeToBioMedX 🌟 We are delighted to welcome Suchismita D., our new Recruiting Manager at BioMed X! 🌟 Originally from India, Suchismita holds a Bachelor’s degree in Business Administration. Before joining BioMed X , she has been helping companies in achieving their hiring goals by providing solutions to the critical needs and by implementing the best practices of talent acquisition. 🌟With her prosperous track record in Talent Acquisition, Candidate-Experience and Employer Branding, she aims to make BioMed X more prominent in the global pages of Academia, Industry and Medicine. 🌟She is a believer of continuous training and development, which has helped her in keeping herself updated with the ever-changing market trends in various industries. 🌟Welcome, Suchismita, to the BioMed X Support Team! 💡Are you interested in career opportunities and projects at the interface between academia and industry? Take a look at the BioMed X Institute Career Space: https://bio.mx/career. Christian Tidona
BioMed X Institute
Biotechnologieforschung
Biomedical innovation at the interface between academia and industry
Info
BioMed X is an independent research institute located on the campus of the University of Heidelberg in Germany, with a world-wide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.
- Website
-
https://bio.mx
Externer Link zu BioMed X Institute
- Branche
- Biotechnologieforschung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- 69120
- Art
- Privatunternehmen
- Gegründet
- 2013
- Spezialgebiete
- Biotech, research, pharma, innovation und AI
Orte
-
Primär
Im Neuenheimer Feld 515
69120, Heidelberg, DE
-
55 Church St
New Haven, Connecticut 06510, US
Beschäftigte von BioMed X Institute
-
Thomas Rueckle
-
Christian Tidona
Incurably Curious | BioMed X Institute | XSeed Labs | Building world-class innovation ecosystems for biomedical research, drug discovery and…
-
Eleonora Melzi
DVM PhD - Research Group Leader at BioMed X Institute - Immunology
-
Gorjana Rackov
Group Leader at BioMed X Institute - Immune Cell Dysfunction in Autoimmunity and Neuroinflammation
Updates
-
🎄🍳 Last night, BioMed X traded pipettes for pans in our festive Christmas Cooking Class! From laughter in the kitchen to delicious creations on our plates, it was an evening of collaboration, creativity, and holiday cheer. 🌟🎅🏻 Here’s to mixing science with a dash of culinary fun as we wrap up the year together. BioMed X wishes you all a joyful start to the holiday season and happy time ahead! ❄️ Christian Tidona, Thomas Rueckle, Yvonne Stappenbeck, John Lindner, Mallory Grahnert, Maria Morganti, Merve Pekerli #LifeatBioMedX #HolidaySeason #CookingFun
-
BioMed X Institute hat dies direkt geteilt
Proud to Shape the Future of 𝗘𝗺𝗽𝗹𝗼𝘆𝗲𝗿 𝗕𝗿𝗮𝗻𝗱𝗶𝗻𝗴 at BioMed X Institute. As one of my Onboarding activities, I was honored to represent BioMed X at the recent "HR Breakfast" focus on Employer Branding workshop organized by bioRN Life Science Cluster. This event wasn’t just about strategies and best practices —it was about finding practical and "low hanging fruits" ideas to help our Institute in our aim to: 𝗮𝘁𝘁𝗿𝗮𝗰𝘁𝗶𝗻𝗴 𝗮𝗻𝗱 𝗿𝗲𝘁𝗮𝗶𝗻𝗶𝗻𝗴 𝘁𝗵𝗲 𝗯𝗿𝗶𝗴𝗵𝘁𝗲𝘀𝘁 𝘁𝗮𝗹𝗲𝗻𝘁𝘀 𝗳𝗿𝗼𝗺 𝗮𝗿𝗼𝘂𝗻𝗱 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 𝘁𝗼 𝗷𝗼𝗶𝗻 𝗼𝘂𝗿 𝗺𝗶𝘀𝘀𝗶𝗼𝗻 𝗼𝗳 𝘁𝗿𝘆𝗶𝗻𝗴 𝘁𝗼 𝗮𝗻𝘀𝘄𝗲𝗿 𝘁𝗵𝗲 𝘁𝗼𝘂𝗴𝗵𝗲𝘀𝘁 𝗯𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀🌍 For me, this challenge is deeply personal. Employer branding is more than a buzzword; it’s about showing the world who we are, what we stand for, and why an experience at BioMed X is an extraordinary and unique chance for the researchers in the biomedical field 🌟 As a representative of BioMed X, I feel incredibly proud and energized to be part of shaping our story—a story that will resonate with exceptional minds worldwide and help us push the boundaries of science together💡 Thanks to stephanie fueller from bioRN Life Science Cluster for the organisation and Leonie Herold from COMMHA Consulting to have coordinated the workshop greatly!
-
🎉 Congratulations, Olivia Amanda Oest Müllertz! 🎉 We are thrilled to celebrate a remarkable achievement by Olivia, a PhD student on our 𝗧𝗠𝗜 team, who has been awarded the 𝗧𝗼𝗽 𝗣𝗼𝘀𝘁𝗲𝗿 𝗔𝘄𝗮𝗿𝗱 at the Controlled Release Society – CRS 2024 Annual Meeting! 🏆 The award recognizes Olivia's outstanding research and her abstract titled: "Intestinal mononuclear phagocytes facilitate macromolecular transport across the intestinal epithelium." 👏 Join us in congratulating Olivia on this incredible accomplishment! We are so proud of her hard work, dedication, and ingenuity. 💡 Let's continue to push boundaries and inspire innovation in delivery science together. Are you interested in career opportunities at the interface between academia and industry? Take a look at the 𝗕𝗶𝗼𝗠𝗲𝗱 𝗫 Institute Career Space: https://bio.mx/career. #CRS2024 #TopPoster #PharmaResearch #InnovativeScience #DeliveryScience #TeamAchievement #TMI
-
#WelcomeToBioMedX 🌸We are happy to welcome Rakesh HS, our new intern in team VPE – Virtual Patient Engine. 🌸Rakesh is originally from Davanagere, India, where he obtained a bachelor’s degree in Electronics and Communication from Visvesvaraya Technological University. Afterward, he worked for two years at Tech Mahindra. Later, he moved to Heidelberg, Germany, where he is currently pursuing a master’s degree in Applied Data Science and Analytics at SRH University. 🌸Welcome, Rakesh, and good luck! 💡Are you interested in career opportunities at the interface between academia and industry? Take a look at the BioMed X Institute Career Space: https://bio.mx/career. Douglas McCloskey #VirtualPatientEngine #Bioinformatics #Internship #ComputationalBiology #Career
-
AI-Driven Drug Development: Safer, But Is It also More Effective?🚀 Recent studies (link in first comment) reveal that #AI-derived drugs have a higher success rate in phase 1 clinical trials compared to historic averages. Yet, efficacy remains a challenge, with no notable improvement in phase 2 and 3 success rates. 📊 What does this mean for the future of drug development? 🔬 Higher safety: AI-discovered molecules have an 80–90% success rate in phase 1 clinical trials, substantially higher than historic industry averages. 📈 Comparable efficacy: In phase 2, the success rate is ∼40%, based on a limited sample size, similar to historic industry averages. 🧩 Room for growth: No significant improvements have been observed in phase 3 success rates, leaving clinical efficacy prediction an open challenge. Predicting clinical efficacy remains an unsolved puzzle—and that’s where the #VPE Team, led by Douglas McCloskey, is focusing their efforts at BioMed X Institute. 💡 Join us TONIGHT for our webinar in partnership with Code Ocean: AI Agents for Pharma R&D 📅 When: ❗New Date ❗December 17th, 2024 | 12 pm EST / 9 am PT 📍 Where: https://lnkd.in/eXZs5Gtr Let’s collaborate to shape the future of AI in drug development. Share your insights! 💬 #AIinPharma #DrugDevelopment #ClinicalTrials #PharmaRND #ArtificialIntelligence #LifeSciences #DrugDiscovery #HealthTech #Innovation #MedTech #AIResearch
-
💡From Lab to Hometown: Dr. Stefanie Bärthel shares her research at her hometown during the Heimspiel Wissenschaft! 💡 We’re proud to share that our Team #NST Group Leader, Stefanie Bärthel, was selected to present her research at the Heimspiel Wissenschaft on November 22! 🧬🗣️ Heimspiel Wissenschaft is a joint project by the Hochschulrektorenkonferenz (HRK), the science communication agency con gressa, and the #WisskommLab of the Heidelberg University, with the mission of making science accessible to local communities. 🏡🔬 Returning to her hometown in East Germany, Stefanie captivated the audience with her presentation titled: „Geheime Gespräche im Tumor: Wie Tumor- und Immunzellen miteinander kommunizieren” (Secret conversations inside a tumor: How tumor and immune cells communicate with each other). 🧑🔬🧠 This initiative, funded by the BMBF, brings researchers back to their roots, allowing them to share their groundbreaking work with local communities. 💬 "It was a great experience to share my research on tumor-immune cell communication with my hometown community. Connecting with familiar faces and inspiring curiosity about science was truly rewarding." — Dr. Stefanie Bärthel A big thank you to everyone who attended and supported this inspiring event! Special thanks to Clara Händeler (con gressa) and David Plessy for their support and organization. 🙌 #HeimspielWissenschaft #BMBF #ScienceCommunication #CancerResearch #Immunology #LocalScience #BioMedX #WisskommLab #Hermsdorf
-
#WelcomeToBioMedX 🌸We are happy to welcome Sanjana Balaji Kuttae, our new research assistant in team VPE – Virtual Patient Engine. 🌸Sanjana is originally from Chennai, India, where she obtained a bachelor’s degree in bioinformatics from SRM IST Chennai. Then, she moved to Saarbrucken, Germany and earned her master’s degree from Universität des Saarlandes, Saarbrucken. For her master thesis, she collaborated with INM-Leibniz Institute for New Materials, and worked on computational and experimental characterization of optogenetic systems in E. coli. 🌸Welcome, Sanjana, and good luck! Are you interested in career opportunities at the interface between academia and industry? Take a look at the BioMed X Institute Career Space: https://bio.mx/career. Douglas McCloskey #VirtualPatientEngine #Bioinformatics #ResearchAssistant #ComputationalBiology #Career
-
🎉 News from Yesterday’s Digital Health Triumphs at EMBL! 🎉 Yesterday, on November 18, 2024, the Digital Health Triumphs event at EMBL brought together leading minds in AI and healthcare. We are proud to share that Douglas McCloskey, Team Lead of the Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates (#VPE), made a significant impact with his presentation. 🌐🧬 The event was a fantastic opportunity for Douglas to engage with top industry experts, exchanging knowledge on the future of digital health and AI in drug discovery. 💬 Key Highlights from Douglas’s Session: 👉Generative AI for biomedical diagnostic applications from image modalities (e.g., CT scans) has become state of the art as a result of implementing smart adaptations to existing image and video generative AI technologies. 👉However, limiting access to patient data has and continues to hamper its clinical impact where generalization and accuracy are paramount. 👉AI Agentic workflows could make biomedical diagnostic applications from image modalities more accessible by providing a easy to use natural language interface to clinicians for a technology that requires strong domain expertise to use. Thank you to everyone who attended and supported this incredible event! 🙌 For more details, visit: Digital Health Triumphs - EMBL: https://lnkd.in/epd33Ysg Douglas McCloskey | Daniela Beyer | Alyssa V. Are you interested in how AI agents can revolutionize Pharma R&D by seamlessly communicating with PK/PD/QSP models and Biomedical Knowledge Graphs? 📊🤖 Don’t miss our upcoming webinar in collaboration with: Code Ocean: AI Agents for Pharma R&D 📅 Date: November, 26, 2024 ⏰ Time: 6 pm Berlin / 12 pm EST / 9 am PT Register Now: AI Agents for Pharma R&D https://lnkd.in/eXZs5Gtr #BioMedX #DigitalHealthTriumphs #VirtualPatients #ClinicalTranslation #DrugDiscovery #EMBL2024 #AIinHealthcare #SanofiCollaboration
-
🚀 Exciting Highlights from the AI Driven Drug Discovery Summit! 🚀 Our #VPE Team Lead, Douglas McCloskey, represented BioMed X Institute with inspiring insights at the AI Driven Drug Discovery Summit in Boston from November 12-14! 🌐✨ He shared the latest advancements from his #VPE Team, which, in partnership with Sanofi, is pioneering research on the Next Generation Virtual Patient Engine to accelerate the clinical translation of drug candidates. He also engaged with top industry leaders on the future of AI-driven drug discovery, fostering insightful discussions on its transformative potential. Douglas also joined QIAGEN’s pre-day Knowledge Graph Insight Session, diving into the powerful role of knowledge graphs in modern biopharma research. 📊🤖 Here’s a quick recap of the summit highlights: 👉 Virtual patients (sometimes referred to as DigitalTwins) have the potential to reduce #DrugDiscovery and #DrugDevelopment in the #Pharmaceutical industry time and cost while improving access to life changing treatments to underrepresented patient populations. 👉 High quality (curated) biomedical #KnowledgeGraphs (such as the QIAGEN BKB-HD) are critical enablers to build virtual patients using knowledge-driven or data-driven in silico science. 👉 #AI enabled agentic workflows can expedite manual tasks related to building knowledge graphs and can democratize access to virtual patient technologies. See results (link in the first comment) from our most recent #Hackathon (VPE) "Results for AI agents for life sciences". Thank you to everyone who connected with us at the summit! We’re thrilled to bring back valuable insights and continue driving innovation in clinical translation and drug development. 🙌💡 Douglas McCloskey | Kyle Nilson, PhD | Ted Johnson | Scott J Magin | SHU YAN | Venkatesh Moktali, PhD | Are you interested in how AI agents can revolutionize Pharma R&D by seamlessly communicating with PK/PD/QSP models and Biomedical Knowledge Graphs? 📊🤖 Don’t miss our upcoming webinar in collaboration with Code Ocean: AI Agents for Pharma R&D 📅 Date: November, 26, 2024 ⏰ Time: 6 pm Berlin / 12 pm EST / 9 am PT Register Now: AI Agents for Pharma R&D https://lnkd.in/eXZs5Gtr #BioMedX #AIDrugDiscovery #VirtualPatients #ClinicalTranslation #KnowledgeGraph #Biopharma #InnovationInBiotech #FutureOfMedicine #AIDDD